The UV/sulfite system is a promising source of •SO and/or •OH, but its application is largely limited by the use of UV light due to its high cost and high energy consumption. Graphite carbon nitride (g-CN), as a new photocatalytic material, has better visible light absorption capacity and narrower band gap than g-CN, which is expected to activate sulfite under visible light to solve this problem. Herein, a novel FeS/CN heterojunction material based on g-CN was constructed by hydrothermal in-situ synthesis method and successfully activated sulfite, which was confirmed by tetracycline degradation experiments in water. Under optimized conditions, the degradation rate of TC in 1 h reached 96%. The experimental results revealed that the FeS/CN heterostructure enhances the absorption of visible light and inhibits the recombination of carriers, enabling more electrons and holes to be utilized. Holes play a major role in the degradation reaction, promote the sulfite chain reaction, and effectively regulate the cycle of Fe and Fe in the solution. Iron ion leaching is negligible and the degradation reaction remains stable at pH 5-9.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.envres.2023.116939DOI Listing

Publication Analysis

Top Keywords

visible light
12
degradation reaction
8
degradation
5
heterojunction photocatalyst
4
photocatalyst fes/g-cn
4
fes/g-cn activating
4
activating sulfites
4
sulfites degrade
4
degrade tetracycline
4
tetracycline stable
4

Similar Publications

Objective: This study aims to explore the potential role of mesenchymal stem cells (MSCs) in the treatment of osteoarthritis (OA), particularly the function of the NOTCH1 signaling pathway in maintaining the stemness of MSCs and in chondrocyte differentiation.

Methods: Utilizing diverse analytical techniques on an osteoarthritis dataset, we unveil distinct gene expression patterns and regulatory relationships, shedding light on potential mechanisms underlying the disease. Techniques used include the culture of MSCs, induction of differentiation into chondrocytes, establishment of stable cell lines, Western Blot, and immunofluorescence.

View Article and Find Full Text PDF

Background: Postoperative delirium (POD) is the most common neurological adverse event among elderly patients undergoing surgery. POD is associated with an increased risk for postoperative complications, long-term cognitive decline, an increase in morbidity and mortality as well as extended hospital stays. Delirium prevention and treatment options are currently limited.

View Article and Find Full Text PDF

Background: Wrist synovitis often leads to persistent pain, swelling, and limited mobility, causing significant functional impairment and psychological distress, including anxiety. Although arthroscopic synovectomy can alleviate physical symptoms, whether it also improves anxiety and the causal relationship between synovitis and anxiety remains unclear.

Methods: A prospective study was conducted on 44 patients diagnosed with wrist synovitis who underwent arthroscopic synovectomy.

View Article and Find Full Text PDF

Background And Purpose: Despite the increasing integration of information technologies in healthcare settings, limited attention has been given to understanding technostress among health practitioners in hospitals. This study aims to assess the prevalence of technostress creators among health practitioners and explore potential factors contributing to its occurrence, with the ultimate goal of informing strategies to mitigate its impact.

Method: Data were collected through a validated questionnaire administered to health practitioners at Tehran Apadana Hospital in Iran.

View Article and Find Full Text PDF

Background: Stillbirth occurs at a rate of 3.0 per thousand in Sweden. However, few studies have focused on the initial experiences of parents facing a stillbirth.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!